エディットフォース株式会社

Active

EditForce develops drugs and seeds by using nucleic acid manipulation technologies.

What it does

"EditForce is a deeptech company that leverages RNA editing technology developed at Kyushu University to pioneer new standards in various fields such as healthcare, industry, and agriculture. With a foundation in innovative RNA editing technology, EditForce aims to set new global standards by taking a unique approach different from traditional RNA editing techniques. In their drug development program, they utilize proprietary RNA editing technology to advance their pharmaceutical business. By developing a novel gene manipulation technology based on PPR proteins found in plants, EditForce is at the forefront of creating new genetic editing techniques. Their focus is on establishing treatment methods for various diseases in the pharmaceutical sector, with future plans to expand into creating new value in diverse fields such as chemical and agricultural industries."

Its site says now · captured 2026-08-23

エディットフォース株式会社 - New Tools Lead to a New World

九州大学発のRNA編集技術にもとづく創薬開発をおこなう、エディットフォース株式会社。独自のRNA編集技術を活用し、医療、産業、農業などの様々な分野において新たな世界標準をつくります。

Next to it in Healthcare and bio · RNA editing drug development

  • Crafton Biotechnology株式会社Plug and Play

    Crafton Biotechnology Co. is a manufacturing company that researches, develops, and sells pharmaceutical products.

  • ANA TherapeuticsSOSV SOSV Portfolio: Po Bronson

    Investigating niclosamide as a treatment for COVID-19

  • SOCIUM IncPlug and Play

    SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules.

  • サスメド株式会社Plug and Play

    Sustainable Medicine AI automatic analysis system Development company.

  • Epsilon Molecular EngineeringPlug and Play

    Creation of The Future with Functional Biomolecules

  • Magellan Life SciencesSOSV SOSV IndieBio RebelBio 05

    Discovering, deciphering, and developing unique plant proteins using synthetic biology

  • Intrinsic Medicine (fka Lupa Bio)SOSV SOSV IndieBio 09

    Developing the next generation of essential, disease-modifying medicines

  • Cell Reserves IncSOSV SOSV IndieBio RebelBio 03

    Developing novel protein and peptide-based therapeutics for the treatment of diseases